OFIX Valuation

Orthofix Medical Inc

Add to Watchlist

Advanced Chart

10.670

+0.04(0.376%)1D

Overview
Forecast
Valuation
Earnings

OFIX Relative Valuation

OFIX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, OFIX is overvalued; if below, it's undervalued.

Historical Valuation

Orthofix Medical Inc (OFIX) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.52 is considered Undervalued compared with the five-year average of -1.58. The fair price of Orthofix Medical Inc (OFIX) is between 20.42 to 34.59 according to relative valuation methord. Compared to the current price of 10.63 USD , Orthofix Medical Inc is Undervalued By 47.94%.

Relative Value

Fair Zone

20.42-34.59

Current Price：10.63

47.94%

Undervalued

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

0.91

P/B

Median3y

1.05

Median5y

1.43

-1.15

FCF Yield

Median3y

-10.04

Median5y

-4.71

Competitors Valuation Multiple

The average P/S ratio for OFIX's competitors is 2.14, providing a benchmark for relative valuation. Orthofix Medical Inc Corp (OFIX) exhibits a P/S ratio of 0.51, which is -76.36% above the industry average. Given its robust revenue growth of 2.67%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap